التفاصيل البيبلوغرافية
| العنوان: |
Trends in use of specialized formula for managing cow's milk allergy in young children. |
| المؤلفون: |
Mehta, Shriya, Allen, Hilary I., Campbell, Dianne E., Arntsen, Karoline Fagerli, Simpson, Melanie Rae, Boyle, Robert J. |
| المصدر: |
Clinical & Experimental Allergy; Jul2022, Vol. 52 Issue 7, p839-847, 9p, 1 Color Photograph, 2 Charts, 4 Graphs |
| مصطلحات موضوعية: |
MILK allergy, GOAT milk, INFANT formulas, PUBLIC health |
| مصطلحات جغرافية: |
NORWAY, ENGLAND, AUSTRALIA |
| مستخلص: |
Background: Excessive use of specialized formula for cow's milk allergy was reported in England, but complete analysis has not been undertaken and trends in other countries are unknown. Some specialized formula products, especially amino‐acid formula (AAF), have high free sugars content. We evaluated specialized formula trends in countries with public databases documenting national prescription rates. Methods: Cross‐sectional analysis of national prescription databases in the United Kingdom, Norway and Australia. Outcomes were volume and cost of specialized formula, and proportion of infants prescribed specialized formula. Expected volumes assumed 1% cow's milk allergy incidence and similar formula feeding rates between infants with and without milk allergy. Results: Prescribed volumes of specialized formula for infants rose 2.8‐fold in England from 2007 to 2018, with similar trends in other regions of the United Kingdom. Volumes rose 2.2‐fold in Norway from 2009 to 2020 and 3.2‐fold in Australia from 2001 to 2012. In 2020, total volumes were 9.7‐ to 12.6‐fold greater than expected in England, 8.3‐ to 15.6‐fold greater than expected in Norway and 3.3‐ to 4.5‐fold greater than expected in Australia, where prescribing restrictions were introduced in 2012. In Norway, the proportion of infants prescribed specialized formula increased from 2.2% in 2009 to 6.9% in 2020, or 11.2‐ to 13.3‐fold greater than expected. In 2020, specialized formula for infants cost US$117 (103 euro) per birth in England, US$93 (82 euro) in Norway and US$27 (23 euro) in Australia. Soya formula prescriptions exceeded expected volumes 5.5‐ to 6.4‐fold in England in 1994 and subsequently declined, co‐incident with public health concerns regarding soya formula safety. In 2020, 30%–50% of prescribed specialized formula across the three countries was AAF. Conclusions: In England, Norway and Australia, specialized formula prescriptions increased in the early 21st century and exceeded expected levels. Unnecessary specialized formula use may make a significant contribution to free sugars consumption in young children. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical & Experimental Allergy is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
